Outset Medical to Report Third Quarter 2021 Financial Results on Wednesday, November 3, 2021

Rhea-AI Summary

Outset Medical, Inc. (NASDAQ: OM) will release its third-quarter 2021 financial results after the market closes on November 3, 2021. A conference call hosted by CEO Leslie Trigg and CFO Nabeel Ahmed will take place at 2:00 PM PT to discuss these results. The Tablo® Hemodialysis System, which simplifies and reduces costs associated with dialysis, exemplifies Outset's innovation in improving patient care. The system enables dialysis to be provided anywhere with integrated technology for data analytics and water purification.

Positive

• Technology advancement with the Tablo® Hemodialysis System, improving dialysis care.
• FDA cleared system offers cost and operational efficiencies.

Negative

• None.

SAN JOSE, Calif.--(BUSINESS WIRE)-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the third quarter of 2021 after the close of trading on Wednesday, November 3, 2021.

On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Leslie Trigg, Chief Executive Officer, and Nabeel Ahmed, Chief Financial Officer, will host a conference call to discuss financial and operating results.

Conference Call Details

The conference call will begin at 2:00 pm Pacific Time (5:00 pm Eastern Time) on Wednesday, November 3, 2021. Interested parties may access the live teleconference by dialing (833) 614-1409 for domestic callers or (914) 987-7130 for international callers, followed by conference ID: 7975557. A live and archived webcast of the event will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.

About Outset Medical, Inc.

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo® Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211020005936/en/

Lynn Lewis or Brian Johnston

Gilmartin Group

investors@outsetmedical.com

Source: Outset Medical, Inc.

FAQ

What are the financial results for Outset Medical in Q3 2021?

Outset Medical will announce its Q3 2021 financial results on November 3, 2021.

When is the Outset Medical conference call for Q3 results?

The conference call is scheduled for November 3, 2021, at 2:00 PM PT.

Where can I access the Outset Medical Q3 2021 conference call?

Callers can access the conference call by dialing (833) 614-1409 for domestic and (914) 987-7130 for international.

What is the significance of the Tablo® Hemodialysis System?

Tablo aims to reduce the cost and complexity of dialysis, offering a flexible solution for patient care.